Sequence: EK(EK)4
| Experiment Id | EXP000651 |
|---|---|
| Paper | Investigation of enhanced intracellular delivery of nanomaterials modified with novel cell-penetrati |
| Peptide | EK-(EK)4-lipid |
| Delivery Success Class | no |
| In Vivo Flag | no |
| Uptake Confirmed | yes |
| Label Confidence | high |
| In Vitro Functional Effect | no |
| Endosomal Escape Evidence | |
| Peptide Concentration | 6 mol% lipid |
| Rna Concentration | |
| Mixing Ratio | |
| Formulation Format | liposomes |
| Formulation Components | PEGylated liposomes ± CPP-lipid |
| Size Nm | 80.00 |
| Zeta Mv | |
| Model Scope | in_vitro |
| Model Type | in vitro |
| Cell Lines Or Primary Cells | A549; MIA Paca-2; Colon-26; NIH3T3 |
| Animal Model | |
| Administration Route | |
| Output Type | cellular association |
| Output Value | Enhanced cellular association vs PEGylated control (varies by sequence) |
| Output Units | |
| Output Notes | Flow cytometry and confocal microscopy; no in vivo experiments. |
| Toxicity Notes | No significant cytotoxicity reported. |
| Curation Notes |